ClinicalTrials.gov
public full text
Public Domain
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC#1149980
- NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy#181769
- Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Stage III NSCLC#353292
- ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC#174894
- Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC#174860
Record · ID 148734
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive